Growth Metrics

Gilead Sciences (GILD) Assets Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3.11%
Dec 31, 2025 -2.24%
Sep 30, 2025 -2.19%
Jun 30, 2025 -3.94%
Mar 31, 2025 -3.64%
Dec 31, 2024 -4.60%
Sep 30, 2024 -6.68%
Jun 30, 2024 -7.63%
Mar 31, 2024 -5.87%
Dec 31, 2023 -3.16%
Sep 30, 2023 0.81%
Jun 30, 2023 3.68%
Mar 31, 2023 1.18%
Dec 31, 2022 0.83%
Sep 30, 2022 1.89%
Jun 30, 2022 -0.18%
Mar 31, 2022 0.13%
Dec 31, 2021 2.19%
Sep 30, 2021 1.43%
Jun 30, 2021 1.32%
Mar 31, 2021 1.06%
Dec 31, 2020 -0.90%
Sep 30, 2020 -1.99%
Jun 30, 2020 -2.45%
Mar 31, 2020 1.16%
Dec 31, 2019 2.65%
Sep 30, 2019 1.47%
Jun 30, 2019 8.14%
Mar 31, 2019 9.57%
Dec 31, 2018 7.18%
Sep 30, 2018 8.29%
Jun 30, 2018 18.61%
Mar 31, 2018 19.49%
Dec 31, 2017 26.57%
Sep 30, 2017 30.88%
Jun 30, 2017 24.53%
Mar 31, 2017 27.14%
Dec 31, 2016 36.14%
Sep 30, 2016 36.07%
Jun 30, 2016 30.24%
Mar 31, 2016 29.08%
Dec 31, 2015 34.53%
Sep 30, 2015 34.17%
Jun 30, 2015 24.08%
Mar 31, 2015 24.31%
Dec 31, 2014 26.06%
Sep 30, 2014 31.66%
Jun 30, 2014 34.96%
Mar 31, 2014 29.30%
Dec 31, 2013 24.88%
Sep 30, 2013 25.18%
Mar 31, 2013 27.58%
Dec 31, 2012 29.86%
Sep 30, 2012 32.87%
Jun 30, 2012 34.71%